Blogs: The Reinvented Pharmacist

Do Health Care Ethics Need to Change?

Published Online: Tuesday, September 24, 2013
A recent article in the Wall Street Journal titled “Doctors Face New Scrutiny Over Gifts” describes how pharmaceutical and medical device companies must now report how much they spend on individual physicians. These expenditures can range from pizza brought by sales reps to doctor’s offices to compensation paid to doctors in exchange for expert advice on research. The article suggests that, as a result of these new reporting requirements, many physicians are reconsidering how they relate to these companies.
 
As I read the article, I asked myself, “Is this really necessary?” If it is, why didn’t the medical profession or the industry police itself before the federal government had to get involved? The other question I asked myself, of course, was what about pharmacists? As we play a bigger role in determining which drugs patients use, could we be subject to the same scrutiny? Are you ready to have a spotlight shined on the compensation you receive from industry? Of course, these payments are not automatically unethical, but unfortunately perception can become reality. So, avoiding any hint of unethical behavior may be the best course of action. Based on the Wall Street Journal article, it sounds like that is the decision some physicians have made.
About
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times
Blog Info
This blog focuses on what our Editor-in-Chief sees as the future of pharmacy.
Author Bio
Fred Eckel, RPh, MS, is the Editor-in-Chief of Pharmacy Times, a position he has held since 2002. Mr. Eckel is a professor at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. He serves as executive director of the North Carolina Association of Pharmacists.

In this blog, Eckel will provide commentary on relevant issues impacting pharmacists and pharmacy professionals, including the merging of pharmacy benefit managers, the implications of health care reform, the conversion of major drugs from prescription to over-the-counter, trends in pharmacy careers, and opioid abuse. He will also discuss legislative issues that impact pharmacists, and comment on the evolving role of the pharmacist.
Blog Archive
Latest Issues
$auto_registration$